1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Global Markets for Orphan Drugs

Global Markets for Orphan Drugs

  • September 2015
  • -
  • BCC Research
  • -
  • 162 pages

Summary

Table of Contents

This BCC Research report analyzes the therapeutic applications of orphan drugs in rare and orphan diseases as well as regulatory framework, patents, and recent innovations. Includes forecasts from 2014 to 2019.

REPORT HIGHLIGHTS

The global orphan drug market totaled nearly $123 billion in 2014 and will continue to grow to reach nearly $191 billion by 2019, demonstrating a compound annual growth rate (CAGR) of 9.2% during the forecast period (2014 to 2019).

This report provides:

• An overview of orphan drug criteria, the history of the Orphan Drug Act and its influence, advantages inherent in orphan drug designation, and future growth trends.
• Analyses of global market trends, with data from 2013 and 2014, and projections of compound annual growth rates (CAGRs) through 2019.
• Detailed discussion of successful orphan products.
• Detailed analysis of blockbuster orphan drugs.
• The rising influence of pharmacogenomics in the orphan drug market.
• A discussion of specific rare diseases for which orphan drugs exist.
• Analysis of the most promising therapeutic areas in the industry and leading orphan drugs in these areas.
• An outline of legislation and regulation, including public and private agencies involved in support and development.
• Technology trends analysis within the orphan drug market.
• Comprehensive company profiles of major players in the industry.

SCOPE OF THE REPORT

The scope of this study includes orphan drugs used in pharmaceutical markets globally. This report analyzes the therapeutic applications of orphan drugs in rare and orphan diseases as well as regulatory framework, patents, and recent innovations. The report also analyzes each submarket and its applications, projections and market shares. Technological issues include the latest trends and developments.
This report covers U.S. and European markets as well as emerging global markets like India, Japan, China, Singapore, Taiwan, Korea, Canada, Brazil, Africa, Australia, New Zealand, etc.


Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.